ht
microtit
plate
major
tool
use
pharmaceut
industri
explor
chemic
divers
space
identifi
activ
compound
pharmacophor
specif
biolog
target
howev
ht
face
daunt
challeng
regard
fastgrow
number
drug
target
aris
genom
proteom
research
larg
chemic
librari
gener
highthroughput
synthesi
urgent
need
find
new
way
profil
activ
larg
number
chemic
hundr
biolog
target
fast
lowcost
fashion
chemic
microarray
rise
challeng
capabl
identifi
evalu
small
molecul
potenti
therapeut
reagent
past
year
chemic
microarray
technolog
differ
surfac
chemistri
activ
strategi
gener
mani
success
evalu
chemicalprotein
interact
enzym
activ
inhibit
target
identif
signal
pathway
elucid
cellbas
function
analysi
success
chemic
microarray
technolog
provid
unpreced
possibl
capabl
parallel
function
analysi
tremend
amount
chemic
compound
studi
interact
chemic
compound
biolog
target
domin
modern
drug
discoveri
research
genom
proteom
studi
indic
potenti
exist
druggabl
target
howev
target
correspond
fdaapprov
drug
therefor
find
drug
candid
screen
larg
number
chemic
new
target
quick
econom
fashion
becom
one
challeng
task
today
drug
discoveri
process
past
decad
ht
becom
power
tool
identif
activ
compound
pharmacophor
specif
biolog
target
time
highthroughput
synthesi
small
molecul
also
wide
practic
gener
larg
number
chemic
short
time
period
result
differ
ht
method
introduc
wide
util
increas
throughput
reduc
cost
chemic
target
miniatur
biolog
assay
trend
today
assay
develop
laboratori
autom
convent
microtiterplatebas
assay
move
away
format
system
even
platform
microfluid
system
howev
cost
associ
replac
old
system
highthroughput
highprecis
autom
substanti
success
microarray
technolog
genom
proteom
research
given
new
impetu
miniatur
provid
unpreced
possibl
capabl
parallel
function
analys
hundr
even
thousand
bioentiti
microarray
dna
protein
microarray
play
indispens
role
genom
proteom
research
contrast
develop
chemic
microarray
also
call
chemic
compound
microarray
smallmolecul
microarray
capabl
evalu
larg
number
chemic
structur
hundr
biolog
target
slow
process
one
key
problem
develop
chemic
microarray
compound
differ
structur
properti
tradit
screen
solut
phase
individu
reaction
need
isol
well
reaction
reduc
microarray
size
exist
automat
liquid
handl
system
process
reaction
individu
separ
sequenti
reaction
still
kept
solut
phase
therefor
chemic
microarray
technolog
directli
link
chemic
chip
surfac
introduc
howev
compar
dna
protein
microarray
gener
link
technolog
establish
immobil
compound
process
differ
structur
function
group
chip
surfac
avoid
potenti
complic
immobil
process
microarray
dri
compound
develop
technolog
deposit
chemic
compound
librari
chip
surfac
dri
form
howev
differ
compound
possess
differ
dissolut
rate
creat
problem
reaction
uniform
endpoint
data
comparison
recent
chemic
microarray
technolog
also
success
use
cellbas
assay
infus
small
molecul
biodegrad
polym
differ
physic
properti
chemic
compound
would
also
result
differ
diffus
endpoint
given
potenti
low
molecular
weight
chemic
compound
avail
theori
one
might
imagin
mani
difficulti
could
encount
approach
outlin
avoid
problem
new
solutionphas
chemic
compound
microarray
creat
format
compound
individu
array
glass
surfac
reaction
buffer
contain
low
concentr
glycerol
prevent
evapor
therefor
convent
wellbas
screen
chemic
compound
biolog
target
alway
reaction
solut
activ
biolog
target
deliv
analyt
use
aerosol
deposit
technolog
approach
compound
peptid
librari
microarray
activ
biolog
target
form
pure
protein
cell
lysat
review
discuss
recent
develop
form
chemic
microarray
well
applic
limit
direct
drug
screen
develop
chemic
array
could
arisen
byproduct
splitpool
techniqu
follow
develop
highthroughput
librari
synthesi
earli
lam
cowork
describ
onebead
onecompound
approach
gener
peptid
librari
mm
bead
librari
screen
receptor
conjug
fluoresc
dye
report
enzym
approach
eventu
merg
new
dna
microarray
technolog
late
creat
first
type
chemic
microarray
mani
pioneer
studi
perform
schreiber
laboratori
harvard
platform
usual
call
smallmolecul
microarray
smm
use
divers
link
techniqu
immobil
chemic
compound
specif
moieti
coval
coupl
surfac
glass
screen
compound
chosen
biotarget
figur
essenti
requir
form
chemic
microarray
specif
reactiv
group
microarray
surfac
librari
exampl
macbeath
et
al
immobil
compound
contain
thio
group
surfac
maleimidederivat
glass
hergenroth
et
al
gener
alcoholreact
glass
surfac
immobil
compound
contain
hydroxyl
function
winssing
et
al
coval
link
small
molecul
peptid
nucleic
acid
tag
array
oligonucleotid
surfac
approach
winssing
et
al
screen
smallmolecul
microarray
proteas
crude
cell
lysat
identifi
caspas
inhibitor
detect
caspas
activ
kohn
et
al
coupl
azidefunction
molecul
phosphanederivat
microarray
dillmor
et
al
develop
photochemistri
link
chemic
drug
discoveri
today
volum
number
juli
smallmolecul
microarray
chemic
compound
synthes
link
function
group
array
coval
immobil
surfac
microarray
chip
use
standard
microarray
biolog
target
cell
lysat
purifi
form
ad
chip
follow
sever
wash
step
elimin
nonspecif
weak
bind
compound
bind
target
high
affin
identifi
immunoassay
chemic
structur
shown
figur
illustr
purpos
kuruvilla
cowork
publish
interest
studi
use
approach
synthes
structur
complex
small
molecul
use
onebead
onestocksolut
technolog
microarray
glass
slide
smm
screen
fluoresc
label
yeast
prionlik
protein
repressor
transcript
factor
one
eight
hit
primari
bind
screen
activ
secondari
cellbas
screen
assay
dissoci
constant
k
valu
mm
sar
analysi
small
group
deriv
synthes
base
lead
structur
secondgener
compound
emerg
better
solubl
improv
k
mm
interestingli
compound
select
activ
glucosesensit
signal
pathway
nitrogen
nutrientrespons
signal
pathway
research
effect
util
dna
microarray
chemic
microarray
technolog
demonstr
chemic
microarray
technolog
power
tool
select
chemic
ligand
high
bind
activ
perturb
bioactiv
howev
immobil
larg
diversifi
chemic
librari
mani
limit
result
scientist
graffin
pharmaceut
creat
fragment
chemic
microarray
system
immobil
thousand
drug
fragment
pharmacophor
http
wwwgraffinitycomtelementsphp
uniqu
platform
lowcomplex
druglik
compound
synthes
immobil
microarray
special
design
selfassembl
monolay
sam
thin
gold
layer
provid
base
sam
surfac
plasmon
reson
spr
detect
microarray
chip
treat
biolog
target
without
label
plasmon
imag
base
phenomenon
spr
use
record
mass
chang
gener
solubl
protein
bound
immobil
chemic
surfac
wavelength
shift
spr
set
correspond
amount
protein
bound
chemic
surfac
help
creat
proteinligand
affin
fingerprint
approach
druglik
fragment
high
bind
affin
toward
protein
target
quickli
identifi
figur
compar
moretradit
smallmolecul
screen
bind
affin
gener
weaker
system
k
valu
mm
rang
percentag
fragment
capabl
bind
particular
protein
higher
qualiti
lead
compound
also
depend
heavili
initi
screen
data
interpret
therefor
graffin
creat
whole
process
term
rais
rapid
array
inform
structur
evolut
includ
sar
analysi
identif
develop
drug
candid
screen
databas
figur
labelfre
affin
bind
assay
detect
weak
proteinligand
interact
reduc
labor
reagent
cost
simplifi
initi
screen
work
howev
use
chemic
fragment
technolog
util
tremend
valu
exist
chemic
librari
also
clear
answer
mani
fragment
screen
enough
therefor
approach
potenti
lose
lead
bias
microarray
creat
lack
certain
chemic
fragment
immobil
chemic
microarray
smm
fragment
chemic
microarray
technolog
particularli
use
probe
bind
partner
identifi
target
microarray
contain
thousand
compound
pharmacophor
microlit
level
screen
parallel
multipl
biotarget
howev
major
disadvantag
platform
requir
specif
chemistri
coupl
limit
use
exist
chemic
librari
addit
factor
length
flexibl
linker
compound
bind
orient
spatial
hindranc
microarray
surfac
properti
also
affect
target
bind
nevertheless
combin
proteom
genom
research
lead
compound
perturb
biolog
signal
pathway
rapidli
identifi
technolog
process
chemic
librari
avoid
limit
immobil
scientist
abbott
laboratori
gener
new
form
chemic
microarray
put
compound
dissolv
dimethyl
sulfoxid
dmso
polystyren
sheet
dri
chemic
microarray
process
diffus
toward
target
immobil
agaros
gel
figur
process
call
microarray
compound
screen
marc
david
colleagu
first
report
technolog
identifi
inhibitor
hiv
integras
use
agaros
matric
drug
discoveri
today
volum
number
juli
review
fragment
chemic
microarray
thousand
chemic
fragment
synthes
immobil
microarray
coat
thin
layer
gold
treat
chip
target
protein
surfac
plasmon
reson
spr
base
plasmon
imag
use
record
mass
chang
solubl
protein
bind
immobil
chemic
wavelength
shift
spr
correspond
amount
protein
bind
chemic
surfac
creat
proteinligand
affin
fingerprint
sar
analysi
first
gener
druglik
compound
analog
synthes
test
lead
candid
optim
wwwdrugdiscoverytodaycom
contain
introduc
variou
reagent
involv
assay
studi
librari
compound
differ
structur
class
screen
novel
inhibitor
differ
class
identifi
use
similar
approach
abbott
scientist
appli
marc
technolog
differ
enzym
exampl
gopalakrishnan
cowork
use
technolog
screen
caspas
inhibitor
first
discret
compound
spot
dri
onto
polystyren
sheet
size
convent
microtit
plate
agaros
gel
contain
laid
top
compound
follow
second
agaros
gel
peptid
substrat
place
top
enzym
gel
start
reaction
groeb
et
al
freiberg
et
al
report
proteaseand
kinasebas
screen
approach
use
radiometr
detect
method
kinas
figur
one
interest
applic
technolog
use
identifi
agonist
gproteincoupl
receptor
cell
coexpress
human
dopamin
receptor
chimer
g
protein
preload
ca
indic
acetoxymethyl
ester
cast
agaros
gel
place
compound
sheet
agonist
increas
cytosol
ca
level
result
enhanc
fluoresc
upon
bind
intracellular
discoveri
partner
intern
dpi
licens
marc
technolog
abbott
commerci
improv
whole
process
microarray
spot
agaros
gel
cast
imag
data
analysi
dpi
scientist
array
total
chemic
compound
nl
duplic
standard
array
footprint
microtit
plate
use
modifi
gilson
constel
tm
system
syringesolenoid
dispens
technolog
method
compound
dri
immedi
spot
store
gastight
inert
atmospher
futur
assay
although
platform
test
mani
diversifi
target
includ
enzym
receptor
one
major
problem
approach
rate
capabl
resolubil
diffus
differ
class
dri
compound
complic
dynam
rang
array
compound
versu
bioavail
compound
address
question
cheng
et
al
character
diffus
compound
divers
properti
use
liquid
chromatographymass
spectrometri
lcm
determin
much
compound
left
polystyren
sheet
incub
agaros
gel
defin
period
time
expect
studi
found
compound
lower
clogp
show
higher
rate
transfer
agaros
gel
wherea
physic
properti
molecular
weight
size
acid
hbond
properti
less
effect
diffus
rate
studi
demonstr
major
compound
transfer
min
incub
agaros
gel
provid
suffici
amount
compound
screen
purpos
studi
also
reveal
certain
compound
might
transfer
problem
thu
yield
insuffici
concentr
compound
interact
biotarget
particular
problem
vitro
screen
campaign
fast
enzym
reaction
weak
inhibitor
weak
receptor
binder
hydrophob
compound
complex
natur
product
might
involv
differenti
transfer
rate
ht
detect
inhibitor
differ
kinet
time
point
result
incompar
inhibit
profil
would
major
challeng
ic
profil
group
compound
target
reaction
condit
previous
describ
chemic
microarray
technolog
solidphas
format
chemic
compound
array
wellless
wallless
flat
surfac
liquid
handler
activ
compound
individu
tradit
microtiterplatebas
reaction
perform
microarray
reaction
compar
reaction
done
microtit
plate
solutionphas
chemic
microarray
develop
one
first
group
tri
combin
peptid
microarray
technolog
convent
liquid
handl
method
transfer
kinas
reaction
microarray
houseman
colleagu
first
coat
glasssurfac
microarray
peptid
substrat
kinas
prepar
kinas
reaction
solut
convent
plate
includ
chemic
compound
kinas
atp
kinas
reaction
initi
transfer
drug
discoveri
today
volum
number
juli
dri
chemic
microarray
chemic
compound
array
dri
polystyren
sheet
footprint
plate
agaros
gel
embed
enzym
substrat
appli
surfac
array
short
incub
second
gel
contain
radioact
atp
appli
initi
biolog
reaction
final
reaction
detect
use
standard
phosphorimag
kinas
reaction
solut
plate
substrateco
microarray
studi
demonstr
phosphoryl
reaction
inhibit
chemic
compound
could
detect
array
format
howev
approach
ideal
solut
procedur
requir
premix
reagent
well
plate
transfer
substrat
chip
cours
demand
labor
time
liquid
handl
convent
system
attempt
develop
true
solutionphas
chemic
microarray
perform
assay
convent
microtit
plate
diamond
group
univers
pennsylvania
usa
creat
solutionphas
chemic
microarray
use
glycerol
antievapor
reagent
mix
chemic
compound
array
microarray
surfac
activ
solutionphas
chemic
microarray
adapt
aerosol
deposit
technolog
convert
biolog
target
fine
mist
cover
top
whole
microarray
simultan
exploit
technolog
new
tool
drug
screen
reaction
biolog
licens
develop
solutionphas
chemic
microarray
technolog
commerci
product
discoverydot
tm
chemic
microarray
drug
screen
platform
figur
discoverydot
tm
base
principl
microarray
chemic
librari
glass
slide
inch
inch
format
compound
per
microarrayin
nonvolatil
glycerolbas
format
compat
storag
compound
form
individu
wellless
reaction
center
total
volum
nl
biochem
reaction
start
use
aerosol
deposit
technolog
reaction
product
detect
laser
scanner
imag
figur
one
key
element
discoverydot
tm
chemic
compound
target
solut
throughout
whole
process
therefor
exist
chemic
librari
screen
platform
make
technolog
univers
chemic
microarray
date
solutionphas
platform
mimic
convent
larg
volum
wellbas
system
environ
mechan
biochem
reaction
microarray
similar
wellbas
reaction
higher
effici
profil
multipl
biotarget
exampl
microarray
librari
pharmacolog
activ
compound
lopac
polylysineco
slide
poli
glutyr
peptideco
slide
dephosphoryl
myelin
basic
protein
mbp
coat
slide
parallel
polylysin
slide
use
proteas
screen
poli
glutyr
peptideco
slide
use
screen
src
tyrosin
kinas
mbpcoat
slide
use
screen
serinethreonin
protein
kinas
round
screen
proteas
src
yield
mani
inhibitor
unpublish
screen
yield
one
particularli
strong
inhibitor
reaction
perform
plate
format
compound
identifi
similar
potenc
discoverydot
tm
technolog
use
gener
proteom
research
drug
discoveri
gosalia
diamond
publish
technolog
first
show
potenti
power
multiplex
enzymat
reaction
microarray
contain
differ
peptid
substrat
varieti
proteas
identifi
small
molecul
capabl
inhibit
caspas
similarli
et
al
also
identifi
specif
small
molecul
inhibit
differ
caspas
isoform
caspas
peptidesubstr
drug
discoveri
today
volum
number
juli
review
solutionphas
chemic
microarray
exist
chemic
compound
assay
buffer
contain
dimethyl
sulfoxid
dmso
glycerol
array
surfac
microarray
compound
alway
solut
without
chemic
link
microarray
homogen
reaction
biolog
target
substrat
ad
reaction
dot
aerosol
deposit
technolog
case
kinas
reaction
initi
spray
atp
reaction
product
detect
laser
scanner
imag
heterogen
elisabas
reaction
kinas
assay
use
whole
protein
substrat
substrat
immobil
microarray
surfac
first
compound
microarray
kinas
spray
array
reaction
initi
spray
atp
reaction
detect
convent
elisa
protocol
wwwdrugdiscoverytodaycom
microarray
could
also
activ
cell
lysat
pretreat
apoptosi
induc
special
design
peptid
microarray
use
identifi
compound
capabl
modul
apoptosi
pathway
recent
use
peptid
librari
microarray
fluorogen
proteas
substrat
gener
structur
acalaxx
argli
coumarin
gosalia
et
al
profil
human
blood
serin
proteas
human
thrombin
factor
xa
plasmin
urokinas
plasminogen
activ
result
provid
complet
map
proteas
specif
substrat
test
identifi
cooper
interact
substrat
subsit
gosalia
et
al
profil
peptid
serin
proteas
activ
protein
c
plasma
kallikrein
factor
viia
factor
ixab
factor
xia
factor
axiia
activ
complement
tryptas
trypsin
subtilisin
carlsberg
cathepsin
g
papainlik
cystein
proteas
cathepsin
b
h
k
l
v
rhodesain
papain
chymopapain
ficin
stem
bromelain
studi
first
report
substrat
specif
rhodesain
papainlik
cystein
proteas
express
trypanasoma
brucei
rhodesiens
parasit
protozoan
respons
caus
sleep
sick
howev
greatest
potenti
technolog
drug
screen
primari
hit
identif
confirm
secondari
lead
optim
et
al
report
commerci
side
technolog
reveal
detail
aerosol
technolog
applic
creat
homogeneousbas
screen
format
enzym
caspas
matrix
metalloproteinas
thrombin
factor
xa
histon
deacetylas
protein
kinas
natur
homogen
reaction
system
timedepend
dosedepend
reaction
also
perform
microarray
deliv
kinet
paramet
k
v
max
k
cat
fact
author
demonstr
microarraygener
paramet
quantit
similar
deriv
wellbas
assay
exampl
technolog
yield
similar
ic
valu
reaction
condit
use
furthermor
take
advantag
miniatur
pay
larger
scale
ht
total
cost
microarraybas
reaction
could
reduc
compar
standard
low
volum
assay
type
homogeneousbas
ht
proteas
recent
reach
mileston
discoveri
cathepsin
l
inhibitor
screen
campaign
compound
could
potenti
use
treatment
sever
acut
respiratori
syndrom
sar
propos
sar
infect
threestep
process
involv
receptorbind
induc
conform
chang
glycoprotein
follow
proteolysi
cathepsin
l
subsequ
activ
membran
fusion
endosom
compart
inhibit
cathepsin
l
shown
block
entri
sar
coronaviru
sarscov
host
cell
studi
open
new
target
class
drug
develop
therapeut
valuabl
fight
sar
viru
horiuchi
et
al
recent
publish
applic
discoverydot
tm
kinas
primari
screen
profil
heterogen
format
util
tradit
elisa
report
format
kinas
substrat
either
peptid
nativ
protein
immobil
surfac
chip
chemic
librari
array
top
biochem
reaction
activ
aerosol
deposit
enzym
product
phosphoryl
peptid
protein
detect
antibodi
recogn
phosphoryl
product
exampl
use
biotinyl
poli
glutyr
peptid
substrat
csrc
assay
microarray
produc
signaltonois
ratio
z
factor
ht
addit
accur
enzym
kinet
paramet
k
atp
mm
ic
valu
staurosporin
nm
nm
mm
atp
similarli
use
nativ
mek
protein
substrat
nanolit
reaction
braf
microarray
inhibit
expect
ic
nm
compound
select
profil
multipl
target
braf
kinas
insert
domain
receptor
kdr
met
lyn
epiderm
growth
factor
receptor
egfr
plateletderiv
growth
factor
receptor
b
pdgfrb
also
carri
discoverydot
tm
commerci
mainli
biochemicalbas
assay
elisabas
detect
proteinprotein
interact
antibodi
librari
screen
bindingbas
assay
receptorligand
interact
fluoresc
polar
detect
method
also
develop
chemic
microarray
format
mention
mainli
use
screen
chemicalbind
protein
potenti
drug
use
biochem
assay
cellbas
assay
potenti
capabl
develop
exampl
ziauddin
sabatini
develop
reversetransfect
microarray
use
gelatin
immobil
cdna
vector
regular
glasssurfac
chip
upon
cell
grown
studi
gene
function
use
similar
approach
stockwel
sabatini
group
recent
publish
first
chemic
microarray
format
cellbas
highcont
screen
studi
biodegrad
polylactidecoglycolid
plga
copolym
use
impregn
microarray
surfac
mm
diamet
disc
compound
cell
seed
top
compound
slowli
diffus
affect
proxim
cell
plga
use
deliv
protein
drug
enabl
control
releas
protein
small
molecul
combin
drug
diffus
polym
eros
chemic
microarray
technolog
potenti
highthroughput
cellbas
assay
must
overcom
obstacl
becom
use
broad
platform
exampl
find
one
polym
imbed
releas
possibl
million
chemic
compound
differ
physic
properti
challeng
addit
releas
stabil
chemic
affect
assay
comparison
studi
furthermor
author
notic
chip
print
h
use
activ
freshli
print
chip
data
analysi
anoth
challeng
concentr
compound
cell
decreas
center
array
skirt
result
effect
compound
also
decreas
outer
edg
increas
burden
data
analysi
addit
alreadi
complex
format
microtiterplatebas
screen
new
develop
chemic
microarray
technolog
capabl
analyz
hundr
thousand
chemic
multipl
biolog
target
parallel
advanc
ht
miniatur
reaction
parallel
screen
system
applic
target
identif
discoveri
lead
compound
made
promis
platform
use
mani
drug
discoveri
process
reduc
cost
shorten
cycl
time
increas
product
anoth
advantag
technolog
easili
access
evalu
scientist
academia
industri
access
dna
protein
microarray
facil
could
perform
assay
mention
review
certain
modif
base
instrument
avail
addit
market
array
assay
detector
data
analysi
readili
avail
tabl
howev
one
take
advantag
chemic
microarray
correct
platform
select
summari
tabl
use
gener
guid
biochem
assay
exampl
immobil
microarray
platform
prefer
fish
biolog
target
mixtur
biofluid
either
dri
form
gelpad
form
use
almost
chemic
enzym
reaction
cellbas
assay
possibl
use
slowreleas
properti
polym
use
embed
chemic
howev
differ
rate
compound
dissolut
diffus
stabil
make
difficult
observ
uniform
reaction
solutionphas
chemic
microarray
mimic
convent
wellbas
assay
use
homogen
heterogen
assay
virtual
chemic
compound
enzym
proteinprotein
interact
howev
assay
format
limit
present
avail
suitabl
detector
continu
limit
assay
choic
detector
develop
necessari
resolut
sensit
recogn
mm
reaction
center
